chemocentryx inc (CCXI:NASDAQ GS)
Thomas J. Schall Ph.D.
Founder, Chairman of the Board, Chief Executive Officer and President, ChemoCentryx, Inc.
|Age||Total Calculated Compensation||This person is connected to 16 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2012
Dr. Thomas J. Schall, Ph.D. founded ChemoCentryx Inc. in November 1996 and has been its Chief Executive Officer and President since November 1996. Dr. Schall focuses on the discovery and development of chemokine-based therapeutics widely regarded as a Leader in chemokine research, his laboratories have been responsible for the discovery or co-discovery of almost one-third of all known chemokine receptors. From December 1993 to November 1996, he worked at the DNAX ResearchInstitute, ...
850 Maude AvenuePhone: 650-210-2900
Mountain View, California 94043
Board Members Memberships*
Founder, Chairman of the Board, Chief Executive Officer and President
The Board of Trustees of The Leland Stanford Junior University
Northern Illinois University
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
Biogen Idec Inc.
|G. Kelly Martin||Chief Executive Officer and Executive Director|
Elan Corporation, plc
|Eyal Desheh||Interim Chief Executive Officer and Interim President|
Teva Pharmaceutical Industries Limited
|Paul A. Friedman M.D.||Chief Executive Officer, President, Director, Member of Non-Management Stock Option Committee and Member of Finance Committee|
|Yasuchika Hasegawa||Chief Executive Officer, President and Representative Director|
Takeda Pharmaceutical Company Limited
|--||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26